Finally, despite the broad spectrum of beneficial effects demonstrated preclinically by PTI-125’s reversal of FLNA’s altered conformation, Aβ42 signaling via α7nAChR and TLR4 are only two of many pathogenic cascades in AD. The gene discussed is CHRNA7; the disease is Alzheimer disease.